ZA852316B - Pharmaceutical composition and method for treatment or prophylaxis of cardiac disorders - Google Patents
Pharmaceutical composition and method for treatment or prophylaxis of cardiac disordersInfo
- Publication number
- ZA852316B ZA852316B ZA852316A ZA852316A ZA852316B ZA 852316 B ZA852316 B ZA 852316B ZA 852316 A ZA852316 A ZA 852316A ZA 852316 A ZA852316 A ZA 852316A ZA 852316 B ZA852316 B ZA 852316B
- Authority
- ZA
- South Africa
- Prior art keywords
- prophylaxis
- treatment
- pharmaceutical composition
- cardiac disorders
- cardiac
- Prior art date
Links
- 208000020446 Cardiac disease Diseases 0.000 title 1
- 208000019622 heart disease Diseases 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 238000011321 prophylaxis Methods 0.000 title 1
- 238000011282 treatment Methods 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- H—ELECTRICITY
- H04—ELECTRIC COMMUNICATION TECHNIQUE
- H04L—TRANSMISSION OF DIGITAL INFORMATION, e.g. TELEGRAPHIC COMMUNICATION
- H04L65/00—Network arrangements, protocols or services for supporting real-time applications in data packet communication
- H04L65/1066—Session management
- H04L65/1083—In-session procedures
- H04L65/1095—Inter-network session transfer or sharing
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Dermatology (AREA)
- Business, Economics & Management (AREA)
- Multimedia (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- General Business, Economics & Management (AREA)
- Computer Networks & Wireless Communication (AREA)
- Signal Processing (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US59806184A | 1984-04-09 | 1984-04-09 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA852316B true ZA852316B (en) | 1985-11-27 |
Family
ID=24394068
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA852316A ZA852316B (en) | 1984-04-09 | 1985-03-27 | Pharmaceutical composition and method for treatment or prophylaxis of cardiac disorders |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US5017609A (xx) |
| EP (1) | EP0179808B1 (xx) |
| JP (1) | JPH0720861B2 (xx) |
| AU (1) | AU575153B2 (xx) |
| CA (1) | CA1242395A (xx) |
| DE (1) | DE3584560D1 (xx) |
| IT (1) | IT1184271B (xx) |
| WO (1) | WO1985004580A1 (xx) |
| ZA (1) | ZA852316B (xx) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4857552A (en) * | 1988-06-08 | 1989-08-15 | E. I. Du Pont De Nemours And Co. | Stable pharmaceutical composition |
| GR1000509B (el) * | 1988-06-08 | 1992-07-30 | Du Pont | Μεθοδος παρασκευης σταθερης ενεσιμης υδατικης συνθεσεως υδροχλωρικου 3-[4-(2-υδροξυ-3-ισοπροπυλαμινο) προποξυ]-φαινυλοπροπιονικου μεθυλεστερα. |
| US6310094B1 (en) * | 2001-01-12 | 2001-10-30 | Baxter International Inc. | Ready-to-use esmolol solution |
| TWI277414B (en) * | 2001-01-12 | 2007-04-01 | Baxter Int | Esmolol formulation |
| CN1558755A (zh) * | 2001-09-26 | 2004-12-29 | ���ع��ʹ�˾ | 通过分散和除去溶剂或液相制备亚微米大小的纳米颗粒 |
| US7112340B2 (en) * | 2001-10-19 | 2006-09-26 | Baxter International Inc. | Compositions of and method for preparing stable particles in a frozen aqueous matrix |
| UA89781C2 (xx) * | 2004-04-07 | 2010-03-10 | Арес Трейдінг С.А. | Рідкий склад гормона росту $жидкий состав гормона роста |
| JP5214966B2 (ja) * | 2004-07-30 | 2013-06-19 | ノバルティス アーゲー | ２−アミノ−１，３−プロパンジオール化合物およびその類似体の製剤 |
| BRPI0612071A2 (pt) * | 2005-06-14 | 2010-10-19 | Baxter Int | formulações farmacêuticas para minimizar interações entre fármacos |
| WO2007059515A2 (en) * | 2005-11-15 | 2007-05-24 | Baxter International, Inc. | Compositions of lipoxygenase inhibitors |
| WO2008080047A2 (en) * | 2006-12-23 | 2008-07-03 | Baxter International Inc. | Magnetic separation of fine particles from compositions |
| AU2014203121B2 (en) * | 2007-05-22 | 2016-04-21 | Baxter Healthcare Sa | Concentrate esmolol |
| US8426467B2 (en) * | 2007-05-22 | 2013-04-23 | Baxter International Inc. | Colored esmolol concentrate |
| US20080293814A1 (en) | 2007-05-22 | 2008-11-27 | Deepak Tiwari | Concentrate esmolol |
| US8722736B2 (en) * | 2007-05-22 | 2014-05-13 | Baxter International Inc. | Multi-dose concentrate esmolol with benzyl alcohol |
| PL2234614T3 (pl) * | 2007-12-21 | 2013-03-29 | Aop Orphan Pharmaceuticals Ag | Kompozycja farmaceutyczna do pozajelitowego podawania ultrakrótko działającego antagonisty receptora beta-adrenergicznego |
| CA2775317C (en) | 2009-09-22 | 2014-10-28 | Vlife Sciences Technologies Pvt. Ltd. | Topical formulation for diabetic foot ulcers |
| AU2012211318C1 (en) | 2011-01-27 | 2016-08-04 | Baxter Healthcare S.A. | Methods of treating tachycardia and/or controlling heart rate while minimizing and/or controlling hypotension |
| AU2012211309B2 (en) | 2011-01-27 | 2014-10-09 | Baxter Healthcare Sa | Use of (S) - esmolol for controlling venous irritation associated with the treatment of a cardiac disorder |
| CN104473869A (zh) * | 2014-11-20 | 2015-04-01 | 北京京科泰来科技有限公司 | 一种艾司洛尔脂肪乳及其制备方法 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3637852A (en) * | 1963-08-26 | 1972-01-25 | Boehringer Sohn Ingelheim | 1-phenoxy-2-hydroxy-3-isopropylamino-propanes and salts thereof |
| DE1643262C3 (de) * | 1967-12-13 | 1975-06-26 | C.H. Boehringer Sohn, 6507 Ingelheim | i-Phenoxy^-hydroxy-S-alklyaminopropane, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel |
| US4191765A (en) * | 1976-05-25 | 1980-03-04 | Hoechst Aktiengesellschaft | 1-Aryloxy-2-hydroxy-3-aminopropanes |
| US4146630A (en) * | 1976-11-12 | 1979-03-27 | Boehringer Mannheim Gmbh | Blood pressure lowering and adrenergic β-receptor inhibiting 3-(4-phenoxymethylpiperidino)-propyl-phenyl ethers |
| DE2905877A1 (de) * | 1979-02-16 | 1980-08-28 | Boehringer Mannheim Gmbh | Neue aminopropanolderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel |
| DE3015991A1 (de) * | 1980-04-25 | 1981-11-05 | C.H. Boehringer Sohn, 6507 Ingelheim | Neue 1-aryloxy-3-alkylamino-2-propanole und verfahren zur ihrer herstellung |
| SE8004087L (sv) * | 1980-06-02 | 1981-12-03 | Haessle Ab | Nya parasubstituerade 3-fenoxi-1-alkylaminopropanol-2-er med betareceptorblockerande egenskaper, samt forfarande for deras framstellning, farmaceutiska beredningar innehallande desamma, och metod att behandla akut ... |
| US4387103A (en) * | 1980-11-28 | 1983-06-07 | American Hospital Supply Corporation | Method for treatment or prophylaxis of cardiac disorders |
| US4829086A (en) * | 1984-03-14 | 1989-05-09 | Bodor Nicholas S | Soft β-adrenergic blocking agents |
-
1985
- 1985-03-25 JP JP60501518A patent/JPH0720861B2/ja not_active Expired - Fee Related
- 1985-03-25 WO PCT/US1985/000492 patent/WO1985004580A1/en not_active Ceased
- 1985-03-25 EP EP85901817A patent/EP0179808B1/en not_active Expired - Lifetime
- 1985-03-25 AU AU41507/85A patent/AU575153B2/en not_active Ceased
- 1985-03-25 DE DE8585901817T patent/DE3584560D1/de not_active Expired - Lifetime
- 1985-03-27 ZA ZA852316A patent/ZA852316B/xx unknown
- 1985-03-29 CA CA000477920A patent/CA1242395A/en not_active Expired
- 1985-04-05 IT IT47927/85A patent/IT1184271B/it active
-
1989
- 1989-11-16 US US07/437,293 patent/US5017609A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| WO1985004580A1 (en) | 1985-10-24 |
| US5017609A (en) | 1991-05-21 |
| CA1242395A (en) | 1988-09-27 |
| EP0179808B1 (en) | 1991-10-30 |
| IT8547927A0 (it) | 1985-04-05 |
| AU4150785A (en) | 1985-11-01 |
| JPH0720861B2 (ja) | 1995-03-08 |
| IT1184271B (it) | 1987-10-22 |
| AU575153B2 (en) | 1988-07-21 |
| DE3584560D1 (de) | 1991-12-05 |
| EP0179808A4 (en) | 1987-10-27 |
| EP0179808A1 (en) | 1986-05-07 |
| JPS61501775A (ja) | 1986-08-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA852316B (en) | Pharmaceutical composition and method for treatment or prophylaxis of cardiac disorders | |
| IL83925A0 (en) | Compositions for treatment of skin disorders | |
| DE3574228D1 (en) | Rate scanning demand pacemaker and method for treatment of tachycardia | |
| GB2188844B (en) | Pharmaceutical composition for the treatment of psoriasis | |
| SG96694G (en) | Treatment of skin disorders | |
| EG16108A (en) | Method for treatment or prophylaxis of cardiac disorders | |
| IL76071A0 (en) | Method and composition for treatment of cancer | |
| IL77083A (en) | Pharmaceutical compositions containing certain n-acyl-histidyl-prolinamide derivatives or salts thereof for the treatment of amyothropic lateral sclerosis and manufacture thereof | |
| ZA817891B (en) | Method for treatment or prophylaxis of cardiac disorders | |
| AU7896781A (en) | Method for treatment or prophylaxis of cardiac disorders | |
| AU2387988A (en) | Method of treating skin disorders | |
| ZA845271B (en) | Pharmaceutical and veterinary compositions for the treatment of ischemic cardiac disorders | |
| GB8428747D0 (en) | Products for treatment of human body | |
| ZA817931B (en) | Compounds and method for treatment or prophylaxis of cardiac disorders | |
| GB2204488B (en) | Pharmaceutical compositions for the treatment or prophylaxis of skin disorders | |
| AU591107B2 (en) | Psoralene-based bath compositions for treatment of skin disorders | |
| GB2170403B (en) | Medicament for treatment of asthma and preparation thereof | |
| GB8715914D0 (en) | Treatment of cerabral disorders | |
| GB2205743B (en) | Cosmetic method and composition for prevention and/or treatment of dandruff | |
| ZA855613B (en) | Composition and method for the treatment of hemorrhoids | |
| DE3173674D1 (en) | Compounds and method for treatment or prophylaxis of cardiac disorders | |
| ZA881828B (en) | Preparation for treatment of skin disorders | |
| ZA888338B (en) | Pharmaceutical compositions and method of treatment | |
| GB8311803D0 (en) | Treatment of seizure disorders and pharmaceutical compositions | |
| IE842027L (en) | Treatment of skin disorders |